Insiders · Profile

Greene John

Director at CRISPR Therapeutics. Filing since 26 Feb 2025. CIK 0001610732

Company

Date

Role

Action

Shares

Amount

Of holding

CRSP CRISPR Therapeutics AG

26 Feb 2025

Director

Bought

7,000

$313.95K

opened

1 decision on file.